rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
|
17392385 |
2007 |
rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.
|
23918944 |
2013 |
rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors.
|
17508274 |
2007 |
rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.
|
15604628 |
2004 |
rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
|
24366376 |
2014 |
rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
|
25394175 |
2015 |
rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
|
24366402 |
2014 |
rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.
|
24493721 |
2014 |
rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome.
|
19305347 |
2009 |
rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
|
23788249 |
2013 |
rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
|
25356965 |
2015 |
rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
|
20065170 |
2010 |
rs1800709
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.
|
23188549 |
2013 |